Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Ganciclovir 0.15% eye gel |
BNF code | 1103030W0AAAAAA |
Virtual Therapeutic Moiety | Ganciclovir |
Date identifier became valid | 17 Feb 2023 |
Previous product identifier | 408597001 |
Basis of preferred name | rINN - Recommended International Non-proprietary |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Non-availability | Actual Products Available |
Non-availability status date | 14 May 2009 |
Dose form | Continuous |
Virtual Product Ingredient | |
---|---|
Ingredient | Ganciclovir |
Basis of pharmaceutical strength | Based on Ingredient Substance |
Strength value numerator | 1.500 |
Strength value numerator unit | mg |
Strength value denominator | 1.000 |
Strength value denominator unit | gram |
Ontology Drug Form & Route | |
Form & Route | gel.ophthalmic |
Dose Form | |
Formulation | Eye gel |
Drug Route | |
Route | Ocular |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Actual Medicinal Products | |
Virgan 0.15% eye gel (Abacus Medicine Ltd) | |
Virgan 0.15% eye gel (CST Pharma Ltd) | |
Virgan 0.15% eye gel (Thea Pharmaceuticals Ltd) | |
Virtual Medicinal Product Packs | |
Ganciclovir 0.15% eye gel 5 gram |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.